Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

ClinicalTrials.gov ID: NCT02326454

Public ClinicalTrials.gov record NCT02326454. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomised, Double-blind, Placebo Controlled, Study of MR901 in Patients With Moderate to Severe Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Study identification

NCT ID
NCT02326454
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Light Sciences Oncology
Industry
Enrollment
225 participants

Conditions and interventions

Interventions

  • talaporfin sodium Drug
  • Saline Drug
  • Drug Activator 100 J/cm Device
  • Drug Activator 200 J/cm Device

Drug · Device

Eligibility (public fields only)

Age range
40 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2014
Primary completion
Mar 28, 2017
Completion
Mar 28, 2017
Last update posted
Aug 7, 2018

2014 – 2017

United States locations

U.S. sites
41
U.S. states
22
U.S. cities
40
Facility City State ZIP Site status
Not listed Anniston Alabama 36207
Not listed Huntsville Alabama 35801
Not listed Anchorage Alaska 99503
Not listed Laguna Hills California 92653
Not listed Los Angeles California 90017
Not listed Murrieta California 92562
Not listed San Diego California 92120
Not listed Tarzana California 91356
Not listed Denver Colorado 80220
Not listed Aventura Florida 33180
Not listed Bradenton Florida 34205
Not listed Coral Gables Florida 33146
Not listed Pompano Beach Florida 33060
Not listed St. Petersburg Florida 33710
Not listed Tampa Florida 33607
Not listed Bloomington Indiana 47403
Not listed Greenwood Indiana 46143
Not listed New Orleans Louisiana 70006
Not listed New Orleans Louisiana 70115
Not listed Greenbelt Maryland 20770
Not listed Towson Maryland 21204
Not listed Chestnut Hill Massachusetts 02467
Not listed Las Vegas Nevada 89144
Not listed Edison New Jersey 08837
Not listed Albuquerque New Mexico 87109
Not listed Garden City New York 11530
Not listed New York New York 10016
Not listed Newburgh New York 12601
Not listed Poughkeepsie New York 12601
Not listed Concord North Carolina 28025
Not listed Cincinnati Ohio 45212
Not listed Middleburg Heights Ohio 44130
Not listed Springfield Oregon 97477
Not listed Bala-Cynwyd Pennsylvania 19004
Not listed Bryn Mawr Pennsylvania 19010
Not listed Myrtle Beach South Carolina 29572
Not listed Knoxville Tennessee 37923
Not listed Dallas Texas 75231
Not listed Houston Texas 77094
Not listed Salt Lake City Utah 84124
Not listed Mountlake Terrace Washington 98043

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02326454, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 7, 2018 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02326454 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →